COVID-19: Challenges faced by Dialysis Patients
Article No. 340 26 April 2020 COVID-19 has changed the world we live in. Even those who may not have…
Article No. 340 26 April 2020 COVID-19 has changed the world we live in. Even those who may not have…
The kidneys are wonder-organs. They do so many different things. They impact so many life-processes. It is impossible for individuals…
Atypical HUS patients who have progressed to kidney failure and do not have access to a complement inhibitor like Eculizumab have…
(Disclaimer: The information provided here is only indicative. Please check with your doctor or dietician for individual "best practices". There is no single…
Atypical HUS affects about 2-3 per million population according to some estimates. Eculizumab, sold under the brand name Soliris by Alexion…